Gasporox AB (GPX) Fair Value & Analysis
Technology · SE · Market cap 76.2M SEK
Fair value as of: Jun 24, 2026
Analysis
Gasporox AB (GPX) currently trades at kr 6.90, while our model-based Fair Value estimate is kr 6.37 — implying the stock looks roughly 7.7% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Gasporox AB (publ) engages in the development and commercialization of tunable diode laser absorption spectroscopy technology in Sweden. The company offers instruments, such as GPX1500 vial, GPX1500 film pharma, and GPX1500 film food; linearch machines; VialArch, BottleArch, AutoMAP pharma and food, and CellSpect sensors; and GPX HMI software. It also provides laboratory services, including alpha studies, multi-parameter analysis, batch check, stability studies, and customer defined studies; and IQ/OQ protocols, remote calibration services, training, and customized accessories for the GPX1500. Gasporox AB (publ) was incorporated in 2005 and is based in Lund, Sweden.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Gasporox AB (GPX) undervalued?
What is the fair value of GPX?
What is the quality score of GPX?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.